Pfizer lowers cost of Prevnar vaccine for some charity use

Drugmaker Pfizer says it's reducing what it charges humanitarian groups for its blockbuster vaccine against pneumonia, ear and blood infections.

Pfizer Inc.'s move to reduce Prevnar 13's price to $3.10 per dose—but only for the groups' use with refugees and in other emergency settings—follows pressure since 2009 by groups such as Doctors Without Borders.

"This is definitely a step in the right direction and will help to protect millions of ," the charity said.

The biggest U.S. drugmaker previously preferred tax-deductible donations, which don't impact Prevnar's much-higher price. Pfizer's top-selling product, which requires three doses, brings it some $5 billion a year.

Britain's GlaxoSmithKline Plc in September reduced the price of its rival Synflorix pneumococcal vaccine to $3.05 per dose for use in humanitarian emergencies.


Explore further

Pfizer stops China vaccine sales as import license expires

© 2016 The Associated Press. All rights reserved.

Citation: Pfizer lowers cost of Prevnar vaccine for some charity use (2016, November 11) retrieved 18 October 2019 from https://medicalxpress.com/news/2016-11-pfizer-lowers-prevnar-vaccine-charity.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
0 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more